AngioDynamics

Company Snapshot

Founded: 1988
Entity Type: Public
Employees: 675
Region: U.S.
Revenue: $292.5 Millions
Revenue Year: 2024
Headquarter: New York, U.S.
Key Geographics: U.S., International
Corporate Address: 14 Plaza Drive Latham New York 12110 U.S. Tel. +1-(800)-772-6446 www.angiodynamics.com

Company Overview

AngioDynamics provides minimally invasive medical devices used by radiologists, cardiologists and surgeons. It offers a comprehensive portfolio of catheters, mainly angiographic, drainage, dialysis and infusion catheters. The company operates its business through two main areas: Med Tech and Med Device. The Med Tech part focuses on high-tech products such as the AngioVac and AlphaVac systems, which are used to remove blood clots and devices that help dissolve clots using medicine delivered through catheters. The Med Device section includes a wider range of products such as catheters, portsand other basic medical tools used for accessing blood vessels and draining fluids. and AngioDynamics also has several fully owned subsidiaries, including Navilyst Medical, Inc., which makes vascular access products such as BioFlo catheters and PASV valve technology; Vortex Medical, Inc., which improves the company's clot removal solutions; RITA Medical Systems, LLC, which specializes in cancer treatment using heat; and Clinical Devices B.V., which supports operations in other countries.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

AngioDynamics In Reports

Global Markets for Catheters

According to BCC Research detailed report on catheters market This report analyzes the market trends of the global catheter market with data from 2024, estimates from 2025, projections of compound annual growth rates...

Intravenous (IV) Therapy and Vein Access: Global Markets

BCC Research Report: Dive into intravenous therapy and vein access market report breaks down revenues, while sales figures are estimated for the five years from 2024 through 2029.

Ablation Devices: Technologies and Global Markets

BCC Research Market Report says global market for ablation devices is estimated to increase from $6.5 bln in 2022 to reach $11.3 bln by 2027, at a (CAGR) of 11.8%.

Company's Business Segments

  • Med Tech : This segment provides Auryon Atherectomy System, AngioVac, AlphaVac, Thrombolytic Catheters, and NanoKnife.
  • Med Device : This segment provides peripheral products such as Angiographical Catheters and guidewires, Drainage Products, Micropuncture Kits, Port Technologies, the VenaCure EVLT laser system, and and the Solero Microwave Tissue Ablation (MTA) System.

Applications/End User Industries

  • Healthcare
  • Medical Devices
  • Medical Technology
AI Sentiment